x
Filter:
Filters applied
- Free Access
- ovarian stimulationRemove ovarian stimulation filter
Author
- Kolibianakis, EM2
- Al-Azemi, M1
- Alexander, H1
- Bernabeu, Rafael1
- Blockeel, C1
- Broekmans, F1
- Calhaz-Jorge, C1
- Chapron, Charles1
- Cédrin-Durnerin, Isabelle1
- Devroey, P1
- Domar, Alice D1
- Dracea, L1
- Dray, Géraldine1
- Fatemi, HM1
- Fleming, R1
- Gayet, Vanessa1
- Gleicher, Norbert1
- Gonda, Kelly J1
- Griesinger, G1
- Griesinger, Georg1
- Guerrero, Jaime1
- Hugues, Jean-Noel1
- Humaidan, P1
- Jenkins, J1
- Kolibianakis, Efstratios Michaelis1
Keyword
- IVF3
- GnRH antagonist2
- ovarian reserve2
- androgen receptor1
- anti-Müllerian hormone (AMH)1
- ART1
- CAG polymorphism1
- dehydroepiandrosterone1
- distress1
- endometrial receptivity1
- GnRH agonist1
- GnRH-antagonist1
- gonadotrophin-releasing hormone1
- oestradiol1
- oocyte donor1
- oral contraceptive pill1
- origin1
- ovarian response1
- poor responder1
- poor responders1
- pregnancy1
- pregnancy rat1
- pregnancy rate1
- pretreatment1
Free Access Articles
8 Results
- Review
Insights from clinical experience in treating IVF poor responders
Reproductive BioMedicine OnlineVol. 36Issue 1p12–19Published online: October 25, 2017- Kelly J. Gonda
- Alice D. Domar
- Norbert Gleicher
- Richard P. Marrs
Cited in Scopus: 25‘Poor responders’ is a term used to describe a subpopulation of IVF patients who do not respond well to ovarian stimulation with gonadotrophins. While there is no standard definition of a poor responder, these patients tend to be of advanced maternal age (≥40 years), have a history of poor ovarian response with conventional stimulation protocols, and/or have low ovarian reserve. Despite the heterogeneity of this patient group, there are characteristics and needs common to many poor responders that can be addressed through a holistic approach. - CommentaryOpen Access
To pill or not to pill in GnRH-antagonist cycles: the answer is in the data already!
Reproductive BioMedicine OnlineVol. 31Issue 1p6–8Published online: April 9, 2015- Georg Griesinger
- Christos A. Venetis
- Basil Tarlatzis
- Efstratios Michaelis Kolibianakis
Cited in Scopus: 14The planning of IVF treatment by scheduling menstruation and hence initiation of ovarian stimulation using sex-steroid pre-treatment is commonly used. Pooling data from six randomized-controlled trials encompassing 1343 patients, with and without combined oral contraceptive pill pre-treatment, suggests that the ongoing pregnancy rate per randomized woman is significantly lower in patients with oral contraceptive pill pre-treatment (relative risk [RR]: 0.80, 95% confidence interval [CI]: 0.66–0.97; rate difference [RD]: −5%, 95% CI: −10% to −1%; fixed effects model). - CommentaryOpen Access
Dual ovarian stimulation is a new viable option for enhancing the oocyte yield when the time for assisted reproductive technnology is limited
Reproductive BioMedicine OnlineVol. 29Issue 6p659–661Published online: September 5, 2014- Rebecca Moffat
- Paul Pirtea
- Vanessa Gayet
- Jean Philippe Wolf
- Charles Chapron
- Dominique de Ziegler
Cited in Scopus: 34Ovarian stimulation improves assisted reproductive technology outcome by increasing the number of oocytes available for insemination and in-vitro handling. A recent Duplex protocol features a dual stimulation, with the second stimulation started immediately after the first oocyte retrieval. Remarkably, the Duplex protocol is unexpectadly well tolerated by women and provides twice as many oocytes and embryos as a regular antagonist protocol in less than 30 days. - Article
Androgen receptor CAG repeat length is associated with ovarian reserve but not with ovarian response
Reproductive BioMedicine OnlineVol. 29Issue 4p509–515Published online: July 9, 2014- Belén Lledó
- Joaquin Llácer
- Azahara Turienzo
- Jose Antonio Ortiz
- Jaime Guerrero
- Ruth Morales
- and others
Cited in Scopus: 8The human androgen receptor (AR) gene contains a highly polymorphic CAG repeat sequence within exon 1. In-vitro studies have shown a relationship between CAG repeats in the AR gene and its transactivation potential. This variation in length may play a role in anovulatory infertility. The objective of this study was to investigate whether CAG polymorphism of the AR gene has a predictive value for ovarian reserve, response and cycle outcome in an egg donor programme. CAG length of the AR gene was determined in 147 oocyte donors. - Review
Impact of high serum progesterone during the late follicular phase on IVF outcome
Reproductive BioMedicine OnlineVol. 29Issue 2p177–186Published online: May 16, 2014- Charlotte Sonigo
- Géraldine Dray
- Clémence Roche
- Isabelle Cédrin-Durnerin
- Jean-Noel Hugues
Cited in Scopus: 23With ovarian stimulation for IVF, serum progesterone concentration may increase during the last few days of stimulation. Several factors, mainly the intensity of the ovarian response to gonadotrophins, have been identified to explain progesterone elevation but many other issues remain uncertain. The aim of this narrative, nonsystematic review is to address the nonconsensual issues of the reasons and consequences of premature progesterone elevation during ovarian stimulation. The determination of the optimal threshold above which progesterone elevation may have an impact on IVF outcome is still a matter of debate because it is likely related to the patient's profile. - Review
Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?
Reproductive BioMedicine OnlineVol. 26Issue 5p431–439Published online: February 5, 2013- R. Fleming
- F. Broekmans
- C. Calhaz-Jorge
- L. Dracea
- H. Alexander
- A. Nyboe Andersen
- and others
Cited in Scopus: 48The ability to predict the response potential of women to ovarian stimulation may allow the development of individualized ovarian stimulation protocols. This tailored approach to ovarian stimulation could reduce the incidence of ovarian hyperstimulation syndrome in women predicted to have an excessive response to stimulation or could improve pregnancy outcomes in women classed as poor responders. Namely, variation of the type of gonadotrophin-releasing hormone (GnRH) analogue or the form and dosage of gonadotrophin used for stimulation could be adjusted according to an individual’s response potential. - Commentary
Can oestradiol pretreatment be used to reliably avoid weekend oocyte retrievals?
Reproductive BioMedicine OnlineVol. 24Issue 5p487–489Published online: February 6, 2012- G. Griesinger
- E.M. Kolibianakis
Cited in Scopus: 5Scheduling the initiation of ovarian stimulation in a gonadotrophin-releasing hormone (GnRH)-antagonist protocol by sex steroid pretreatment has been suggested as a means to reduce the incidence of oocyte retrievals during weekends. The rationale is that by manipulating the initiation of gonadotrophin stimulation, Thursday or Friday will be avoided as days on which triggering of final oocyte maturation will be performed and thus weekend oocyte retrievals will not occur. Apparently, the assumption behind such an approach is that duration of stimulation is homogenous enough to serve this purpose reliably. - Review
Elevated progesterone during ovarian stimulation for IVF
Reproductive BioMedicine OnlineVol. 24Issue 4p381–388Published online: January 27, 2012- M. Al-Azemi
- D. Kyrou
- E.M. Kolibianakis
- P. Humaidan
- I. Van Vaerenbergh
- P. Devroey
- and others
Cited in Scopus: 106There is an ongoing debate regarding the impact of premature progesterone rise on the IVF outcome. The objective of this review is to assess evidence of poorer ongoing pregnancy rate in IVF cycles with elevated serum progesterone at the end of follicular phase in ovarian stimulation. It also explores the origin of the progesterone rise, potential modifying factors and possible methods to prevent its rise during ovarian stimulation. This review draws on information already published from monitoring progesterone concentrations at the end of follicular phase in ovarian stimulation.